BCYRN1 and Alzheimer disease: Mus et al. (2007) found that BC200 was significantly up-regulated in AD brains, and this up-regulation in AD was specific to brain areas that are involved, BC200 levels are specifically elevated in area 9, which is involved in the AD, but not in area 17, which is generally not.